{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:13:07Z","timestamp":1790179987901,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Occupational Safety and Health Research Institute","award":["Chemical Research Fund (2023)"],"award-info":[{"award-number":["Chemical Research Fund (2023)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75491-1","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T05:01:51Z","timestamp":1728882111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of the carcinogenic potential of particulate matter generated from 3D printing devices in Balb\/c 3T3-1-1 cells"],"prefix":"10.1038","volume":"14","author":[{"given":"CheolHong","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongSeok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"2","key":"75491_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4055\/cios21181","volume":"14","author":"MW Joo","year":"2022","unstructured":"Joo, M. W., Lee, Y. S., Chung, Y. G. & Lee, H. K. Sarcomas in teachers using three-dimensional printers: a report of three patients and literature review. Clin. Orthop. Surg. 14 (2), 310\u2013317 (2022).","journal-title":"Clin. Orthop. Surg."},{"issue":"6","key":"75491_CR2","doi-asserted-by":"publisher","first-page":"D80","DOI":"10.1080\/15459624.2017.1285489","volume":"14","author":"S Wojty\u0142a","year":"2017","unstructured":"Wojty\u0142a, S., Klama, P. & Baran, T. Is 3D printing safe? Analysis of the thermal treatment of thermoplastics: ABS, PLA, PET, and nylon. J. Occup. Environ. Hyg. 14 (6), D80\u2013D85 (2017).","journal-title":"J. Occup. Environ. Hyg."},{"issue":"20","key":"75491_CR3","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1021\/acs.est.9b04168","volume":"53","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Chemical composition and toxicity of particles emitted from a consumer-level 3D printer using various materials. Environ. Sci. Technol. 53 (20), 12054\u201312061 (2019).","journal-title":"Environ. Sci. Technol."},{"issue":"3\u20134","key":"75491_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/fam.810100303","volume":"10","author":"JV Rutkowski","year":"1986","unstructured":"Rutkowski, J. V. & Levin, B. C. Acrylonitrile-Butadiene-Styrene copolymers (ABS): pyrolysis and combustion products and their toxicity\u2013a review of the literature. Fire Mater. 10 (3\u20134), 93\u2013105 (1986).","journal-title":"Fire Mater."},{"issue":"11\u201312","key":"75491_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/08958378.2020.1834034","volume":"32","author":"MT Farcas","year":"2020","unstructured":"Farcas, M. T. et al. Pulmonary and systemic toxicity in rats following inhalation exposure of 3-D printer emissions from acrylonitrile butadiene styrene (ABS) filament. Inhal Toxicol. 32 (11\u201312), 403\u2013418 (2020).","journal-title":"Inhal Toxicol."},{"issue":"6","key":"75491_CR6","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.3390\/ijms23063216","volume":"23","author":"K Ohmori","year":"2022","unstructured":"Ohmori, K., Kamei, A., Watanabe, Y. & Abe, K. Gene expression over time during cell transformation due to non-genotoxic carcinogen treatment of Bhas 42 cells. Int. J. Mol. Sci. 23 (6), 3216 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"75491_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0014-5793(85)81085-1","volume":"180","author":"T Lund","year":"1985","unstructured":"Lund, T., Holtlund, J. & Laland, S. G. On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells. FEBS Lett. 180 (2), 275\u2013279 (1985).","journal-title":"FEBS Lett."},{"issue":"4","key":"75491_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng0895-436","volume":"10","author":"EF Schoenmakers","year":"1995","unstructured":"Schoenmakers, E. F. et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat. Genet. 10 (4), 436\u2013444 (1995).","journal-title":"Nat. Genet."},{"issue":"3","key":"75491_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ajcp\/109.3.251","volume":"109","author":"JL Hess","year":"1998","unstructured":"Hess, J. L. Chromosomal translocations in benign tumors: the HMGI proteins. Am. J. Clin. Pathol. 109 (3), 251\u2013261 (1998).","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"75491_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/path.1960","volume":"209","author":"VK Sarhadi","year":"2006","unstructured":"Sarhadi, V. K. et al. Increased expression of high mobility group A proteins in lung cancer. J. Pathol. 209 (2), 206\u2013212 (2006).","journal-title":"J. Pathol."},{"key":"75491_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc2271","volume":"7","author":"A Fusco","year":"2007","unstructured":"Fusco, A. & Fedele, M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer. 7, 899\u2013910 (2007).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"75491_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1158\/1541-7786.MCR-07-0095","volume":"6","author":"F Di Cello","year":"2008","unstructured":"Di Cello, F. et al. HMGA2 participates in transformation in human lung cancer. Mol. Cancer Res. 6 (5), 743\u2013750 (2008).","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"75491_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/0008-5472.CAN-09-1212","volume":"70","author":"LM Resar","year":"2010","unstructured":"Resar, L. M. The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res. 70 (2), 436\u2013439 (2010).","journal-title":"Cancer Res."},{"issue":"5","key":"75491_CR14","first-page":"567","volume":"27","author":"SN Shah","year":"2012","unstructured":"Shah, S. N. & Resar, L. M. High mobility group A1 and cancer: potential biomarker and therapeutic target. Histol. Histopathol. 27 (5), 567\u2013579 (2012).","journal-title":"Histol. Histopathol"},{"issue":"14","key":"75491_CR15","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","volume":"73","author":"A Morishita","year":"2013","unstructured":"Morishita, A. et al. HMGA2 is a driver of tumor metastasis. Cancer Res. 73 (14), 4289\u20134299 (2013).","journal-title":"Cancer Res."},{"issue":"8","key":"75491_CR16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1158\/0008-5472.CAN-17-3045","volume":"78","author":"LM Resar","year":"2018","unstructured":"Resar, L. M., Chia, L. & Xian, L. Lessons from the crypt: HMGA1\u2014Amping up wnt for stem cells and tumor progression. Cancer Res. 78 (8), 1890\u20131897 (2018).","journal-title":"Cancer Res."},{"issue":"9","key":"75491_CR17","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3390\/ijms21093151","volume":"21","author":"U Unachukwu","year":"2020","unstructured":"Unachukwu, U., Chada, K. & D\u2019Armiento, J. High mobility group AT-hook 2 (HMGA2) oncogenicity in mesenchymal and epithelial neoplasia. Int. J. Mol. Sci. 21 (9), 3151 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"75491_CR18","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/ncomms15008","volume":"8","author":"L Xian","year":"2017","unstructured":"Xian, L. et al. HMGA1 amplifies wnt signaling and expands the intestinal stem cell compartment and Paneth cell niche. Nat. Comm. 8, 15008 (2017).","journal-title":"Nat. Comm."},{"issue":"1","key":"75491_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du, R., Huang, C., Liu, K., Li, X. & Dong, Z. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. Mol. Cancer. 20 (1), 15 (2021).","journal-title":"Mol. Cancer"},{"issue":"7","key":"75491_CR20","first-page":"970","volume":"7","author":"T Miyagi","year":"1993","unstructured":"Miyagi, T. et al. Expression of the candidate Wilms\u2019 tumor gene, Wt-1, in human leukemia cells. Leukemia. 7 (7), 970\u2013977 (1993).","journal-title":"Leukemia"},{"issue":"5","key":"75491_CR21","first-page":"405","volume":"6","author":"H Miwa","year":"1992","unstructured":"Miwa, H., Beran, M. & Saunders, C. F. Expression of the Wilms\u2019 tumor gene (wt 1) in human leukemias. Leukemia. 6 (5), 405\u2013409 (1992).","journal-title":"Leukemia"},{"issue":"3","key":"75491_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","volume":"90","author":"L Bergmann","year":"1997","unstructured":"Bergmann, L. et al. High levels of Wilms\u2019 tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood. 90 (3), 1217\u20131225 (1997).","journal-title":"Blood"},{"issue":"2","key":"75491_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0609.1999.tb01121.x","volume":"63","author":"A Gaiger","year":"1999","unstructured":"Gaiger, A. et al. Wilms\u2019 tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol. Eur. J. Haematol. 63 (2), 86\u201393 (1999).","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"75491_CR24","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","volume":"84","author":"K Inoue","year":"1994","unstructured":"Inoue, K. et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 84 (9), 3071\u20133079 (1994).","journal-title":"Blood"},{"issue":"5","key":"75491_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<518::AID-IJC5>3.0.CO;2-0","volume":"70","author":"HD Menssen","year":"1997","unstructured":"Menssen, H. D. et al. Detection by monoclonal antibodies of the Wilms\u2019 tumor (WT1) nuclear protein in patients with acute leukemia. Int. J. Cancer. 70 (5), 518\u2013523 (1997).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"75491_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.leu.2401414","volume":"13","author":"P Patmasiriwat","year":"1999","unstructured":"Patmasiriwat, P., Fraizer, G., Kantarjian, H. & Saunders, G. F. WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia. Leukemia. 13 (6), 891\u2013900 (1999).","journal-title":"Leukemia"},{"issue":"5","key":"75491_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.leu.2400620","volume":"11","author":"D Schmid","year":"1997","unstructured":"Schmid, D. et al. Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia. 11 (5), 639\u2013643 (1997).","journal-title":"Leukemia"},{"issue":"3","key":"75491_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.leu.2401341","volume":"13","author":"H Tamaki","year":"1999","unstructured":"Tamaki, H. et al. The Wilms\u2019 tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia. 13 (3), 393\u2013399 (1999).","journal-title":"Leukemia"},{"issue":"15","key":"75491_CR29","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1073\/pnas.94.15.8132","volume":"94","author":"GB Silberstein","year":"1997","unstructured":"Silberstein, G. B., Van Horn, K., Strickland, P., Roberts, C. T. Jr & Daniel, C. W. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc. Natl. Acad. Sci. U S A. 94 (15), 8132\u20138137 (1997).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"75491_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/07357909309018871","volume":"11","author":"W Bruening","year":"1993","unstructured":"Bruening, W. et al. Analysis of the 11p13 wilms\u2019 tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest. 11 (4), 393\u2013399 (1993).","journal-title":"Cancer Invest."},{"issue":"1","key":"75491_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ijc.2910590116","volume":"59","author":"U Rodeck","year":"1994","unstructured":"Rodeck, U. et al. Expression of the wt1 wilms\u2019 tumor gene by normal and malignant human melanocytes. Int. J. Cancer. 59 (1), 78\u201382 (1994).","journal-title":"Int. J. Cancer"},{"key":"75491_CR32","first-page":"201","volume":"93","author":"K Tisljar","year":"1996","unstructured":"Tisljar, K. et al. Detection of WT1 gene expression in patients with solid tumors. Br. J. Haematol. 93, 201 (1996).","journal-title":"Br. J. Haematol."},{"issue":"8","key":"75491_CR33","first-page":"593","volume":"45","author":"N Nonomura","year":"1999","unstructured":"Nonomura, N. et al. Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes. Hinyokika Kiyo. 45 (8), 593\u2013597 (1999).","journal-title":"Hinyokika Kiyo"},{"issue":"2","key":"75491_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1349-7006.1999.tb00733.x","volume":"90","author":"Y Oji","year":"1999","unstructured":"Oji, Y. et al. Expression of the Wilms\u2019 tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J. Cancer Res. 90 (2), 194\u2013204 (1999).","journal-title":"Jpn J. Cancer Res."},{"issue":"19","key":"75491_CR35","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.1158\/1078-0432.CCR-04-0818","volume":"10","author":"K Azuma","year":"2004","unstructured":"Azuma, K. et al. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients. Clin. Cancer Res. 10 (19), 6695\u20136702 (2004).","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"75491_CR36","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/ijc.23400","volume":"122","author":"H Abe","year":"2008","unstructured":"Abe, H. et al. High expression of ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int. J. Cancer. 122 (10), 2391\u20132397 (2008).","journal-title":"Int. J. Cancer"},{"issue":"29","key":"75491_CR37","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1038\/sj.onc.1208214","volume":"24","author":"V Ouellet","year":"2005","unstructured":"Ouellet, V. et al. Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene. 24 (29), 4672\u20134687 (2005).","journal-title":"Oncogene"},{"issue":"3","key":"75491_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.21902","volume":"119","author":"V Ouellet","year":"2006","unstructured":"Ouellet, V. et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int. J. Cancer. 119 (3), 599\u2013607 (2006).","journal-title":"Int. J. Cancer"},{"issue":"8","key":"75491_CR39","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4161\/cbt.29217","volume":"15","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. Cancer Biol. Ther. 15 (8), 1087\u20131093 (2014).","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"75491_CR40","first-page":"157","volume":"18","author":"C Sheng","year":"2018","unstructured":"Sheng, C. et al. Knockdown of ran GTPase expression inhibits the proliferation and migration of breast cancer cells. Mol. Med. Rep. 18 (1), 157\u2013168 (2018).","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"75491_CR41","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/0008-5472.CAN-07-5279","volume":"68","author":"F Xia","year":"2008","unstructured":"Xia, F., Lee, C. W. & Altieri, D. C. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 68(6), 1826\u20131833 (2008).","journal-title":"Cancer Res."},{"issue":"2","key":"75491_CR42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/1078-0432.CCR-11-2035","volume":"18","author":"HF Yuen","year":"2012","unstructured":"Yuen, H. F. et al. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K\/Akt\/mTORC1 and Ras\/MEK\/ERK pathways. Clin. Cancer Res. 18 (2), 380\u2013391 (2012).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"75491_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/cells8030278","volume":"8","author":"Z Dou","year":"2019","unstructured":"Dou, Z. et al. Recent progress on the localization of the spindle assembly checkpoint machinery to kinetochores. Cells. 8 (3), 278 (2019).","journal-title":"Cells"},{"issue":"1","key":"75491_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/cancers10010004","volume":"10","author":"N Vargas-Rond\u00f3n","year":"2017","unstructured":"Vargas-Rond\u00f3n, N., Villegas, V. E. & Rond\u00f3n-Lagos, M. The role of chromosomal instability in cancer and therapeutic responses. Cancers. 10 (1), 4 (2017).","journal-title":"Cancers"},{"issue":"7","key":"75491_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/15459624.2017.1302589","volume":"14","author":"AB Stefaniak","year":"2017","unstructured":"Stefaniak, A. B. et al. Characteristerization of chemical contaminants generated by a desktop fused deposition modeling 3-dimensional printer. J. Occup. Environ. Hyg. 14 (7), 540\u2013550 (2017).","journal-title":"J. Occup. Environ. Hyg."},{"issue":"2","key":"75491_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/15459624.2015.1091957","volume":"13","author":"P Steinle","year":"2016","unstructured":"Steinle, P. Characterization of emissions from a desktop 3D printer and indoor air measurements in office settings. J. Occup. Environ. hyg. 13 (2), 121\u2013132 (2016).","journal-title":"J. Occup. Environ. hyg."},{"issue":"20","key":"75491_CR47","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.1021\/acs.est.5b02805","volume":"49","author":"Y Kim","year":"2015","unstructured":"Kim, Y. et al. Emissions of nanoparticles and gaseous material from 3D printer operation. Environ. Sci. Technol. 49 (20), 12044\u201312053 (2015).","journal-title":"Environ. Sci. Technol."},{"key":"75491_CR48","doi-asserted-by":"publisher","first-page":"836447","DOI":"10.3389\/ftox.2022.836447","volume":"4","author":"A Alijagic","year":"2022","unstructured":"Alijagic, A. et al. Particle safety assessment in additive manufacturing: from exposure risks to advanced toxicology testing. Front. Toxicol. 4, 836447 (2022).","journal-title":"Front. Toxicol."},{"key":"75491_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2019.09.013","volume":"317","author":"MT Farcas","year":"2019","unstructured":"Farcas, M. T. et al. Acrylonitrile butadiene styrene (ABS) and polycarbonate (PC) filaments three-dimensional (3-D) printer emissions-induced cell toxicity. Toxicol. Lett. 317, 1\u201312 (2019).","journal-title":"Toxicol. Lett."},{"issue":"4","key":"75491_CR50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/10915818221093605","volume":"41","author":"MT Farcas","year":"2022","unstructured":"Farcas, M. T. et al. Evaluation of pulmonary effects of 3-D printer emissions from Acrylonitrile Butadiene Styrene using an air-liquid interface model of primary normal human-derived bronchial epithelial cells. Int. J. Toxicol. 41 (4), 312\u2013328 (2022).","journal-title":"Int. J. Toxicol."},{"key":"75491_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2017.09.016","volume":"335","author":"AB Stefaniac","year":"2017","unstructured":"Stefaniac, A. B. et al. Inhalation exposure to three-dimensional printer emissions stimulates acute hypertension and microvascular dysfunction. Toxicol. Appl. Pharmacol. 335, 1\u20135 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"75491_CR52","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.7150\/ijbs.39958","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism. Int. J. Biol. Sci. 16 (8), 1474\u20131480 (2020).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"75491_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/occmed\/kqy042","volume":"68","author":"FL Chan","year":"2018","unstructured":"Chan, F. L. et al. Health survey of employees regularly using 3D printers. Occup. Med. (Lond). 68 (3), 211\u2013214 (2018).","journal-title":"Occup. Med. (Lond)"},{"key":"75491_CR54","doi-asserted-by":"publisher","first-page":"1148974","DOI":"10.3389\/fpubh.2023.1148974","volume":"11","author":"AC Almstrand","year":"2023","unstructured":"Almstrand, A. C. et al. An exporative study on respiratory health among operators working in Polymer additive manufacturing. Front. Public. Health. 11, 1148974. https:\/\/doi.org\/10.3389\/fpubh.2023.1148974 (2023).","journal-title":"Front. Public. Health"},{"issue":"8","key":"75491_CR55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/occmed\/kqx129","volume":"67","author":"R House","year":"2017","unstructured":"House, R., Rajaram, N. & Tarlo, S. M. Case report of asthma associated with 3D printing. Occup. Med. (Lond). 67 (8), 652\u2013654 (2017).","journal-title":"Occup. Med. (Lond)"},{"issue":"11","key":"75491_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/15287394.2016.1166467","volume":"79","author":"J Yi","year":"2016","unstructured":"Yi, J. et al. Emission of particulate from a desktop three-dimensional (3D) printer. J. Toxicol. Environ. Health A. 79 (11), 453\u2013463 (2016).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"75491_CR57","doi-asserted-by":"publisher","first-page":"153100","DOI":"10.1016\/j.tox.2022.153100","volume":"467","author":"NVS Vallabani","year":"2022","unstructured":"Vallabani, N. V. S. et al. Toxicity evaluation of particles formed during 3D-printing: cytotoxicity, genotoxic, and inflammatory response in lung and macrophage models. Toxicology. 467, 153100 (2022).","journal-title":"Toxicology"},{"key":"75491_CR58","doi-asserted-by":"publisher","first-page":"1408842","DOI":"10.3389\/fpubh.2024.1408842","volume":"12","author":"L Barnett","year":"2024","unstructured":"Barnett, L. et al. 3D printer emissions elicit filament-specific and dose-dependent metabolic and genotoxic effects in human airway epithelial cells. Front. Public. Health. 12, 1408842 (2024).","journal-title":"Front. Public. Health"},{"issue":"7","key":"75491_CR59","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgy037","volume":"39","author":"MG Mascolo","year":"2018","unstructured":"Mascolo, M. G. et al. The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro. Carcinogenesis. 39 (7), 955\u2013967 (2018).","journal-title":"Carcinogenesis"},{"key":"75491_CR60","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.3390\/ijms23147603","volume":"23","author":"G Pillo","year":"2022","unstructured":"Pillo, G. et al. Mechanistic interrogation of cell transformation in vitro: the transformics assay as an exemplar of oncotransformation. Int. J. Mol. Sci. 23, 7603 (2022). ()14.","journal-title":"Int. J. Mol. Sci."},{"key":"75491_CR61","doi-asserted-by":"publisher","first-page":"32966","DOI":"10.1038\/srep32966","volume":"6","author":"D Poburski","year":"2016","unstructured":"Poburski, D. & Thierbach, R. Improvement of the Balb\/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies. Sci. Rep. 6, 32966 (2016).","journal-title":"Sci. Rep."},{"issue":"6","key":"75491_CR62","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41419-018-0683-x","volume":"9","author":"F Fu","year":"2018","unstructured":"Fu, F. et al. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration\/invasion via targeting miR-221\/222 in cervical cancer. Cell. Death Disease. 9 (6), 594 (2018).","journal-title":"Cell. Death Disease"},{"key":"75491_CR63","doi-asserted-by":"publisher","first-page":"106732","DOI":"10.1016\/j.phrs.2023.106732","volume":"190","author":"M Hashemi","year":"2023","unstructured":"Hashemi, M. et al. HMGA2 regulation by miRNA in cancer: affecting cancer hallmarks and therapy response. Pharmacol. Res. 190, 106732 (2023).","journal-title":"Pharmacol. Res."},{"issue":"4","key":"75491_CR64","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/jcmm.14082","volume":"23","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Hu, L., Zheng, Y. & Guo, L. HMGA1 in cancer: Cancer classification by location. J. Cell. Mol. Med. 23 (4), 2293\u20132302 (2019).","journal-title":"J. Cell. Mol. Med."},{"issue":"13","key":"75491_CR65","doi-asserted-by":"publisher","first-page":"22235","DOI":"10.18632\/oncotarget.14755","volume":"8","author":"RB Zhou","year":"2017","unstructured":"Zhou, R. B., Lu, X. L., Zhang, C. Y. & Yin, D. C. RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection. Oncotarget. 8 (13), 22235\u201322250 (2017).","journal-title":"Oncotarget"},{"key":"75491_CR66","doi-asserted-by":"publisher","unstructured":"Cheng, Q. et al. Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma. Front. Immunol. 14,\u00a0 1173848. https:\/\/doi.org\/10.3389\/fimmu.2023.1173848 (2023).","DOI":"10.3389\/fimmu.2023.1173848"},{"issue":"7","key":"75491_CR67","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","volume":"13","author":"D Zheng","year":"2023","unstructured":"Zheng, D. et al. Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharm. Sinica B. 13 (7), 2826\u20132843 (2023).","journal-title":"Acta Pharm. Sinica B"},{"key":"75491_CR68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fcell.2020.00345","volume":"8","author":"Z Boudhraa","year":"2020","unstructured":"Boudhraa, Z., Carmona, E., Provencher, D. & Mes-Masson, A. M. Ran GTPase: a key player in tumor progression and metastasis. Front. Cell. Dev. Biol. 8, 345 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"75491_CR69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.21037\/tcr.2019.12.66","volume":"9","author":"MT Shao","year":"2020","unstructured":"Shao, M. T. et al. The overexpression of Zwint in integrated bioinformatics analysis forecasts poor prognosis in breast cancer. Transl. Cancer Res. 9(1), 187\u2013193 (2020).","journal-title":"Transl. Cancer Res."},{"key":"75491_CR70","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.2147\/OTT.S152138","volume":"11","author":"H Ying","year":"2018","unstructured":"Ying, H. et al. Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Onco Targets Ther. 11, 11689\u201311702 (2018).","journal-title":"Onco Targets Ther."},{"issue":"9","key":"75491_CR71","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"S Rao Kondapally Seshasai","year":"2011","unstructured":"Rao Kondapally Seshasai, S. et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364(9), 829\u2013841 (2011).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75491-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75491-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:05:53Z","timestamp":1729256753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75491-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75491"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75491-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23981"}}